Cargando…
Pharmacological trials for long COVID: first light at the end of the tunnel
Autor principal: | Buonsenso, Danilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647474/ https://www.ncbi.nlm.nih.gov/pubmed/36407125 http://dx.doi.org/10.1016/j.lanepe.2022.100544 |
Ejemplares similares
-
Long COVID: an estrogen-associated autoimmune disease?
por: Ortona, Elena, et al.
Publicado: (2021) -
The Covid-19 epidemic: are there lights at the end of the long tunnel?
por: Holden, Patrick
Publicado: (2020) -
Post-COVID-19 condition in children: a COS is urgently needed
por: Munblit, Daniel, et al.
Publicado: (2022) -
Shedding light on the work burden of long COVID
por: Lemogne, Cédric, et al.
Publicado: (2023) -
Light at the end of the tunnel
por: Manohar, Balaji
Publicado: (2013)